Clinical Trial Update: Lung SBRT Motion Management (GCC 1619)

View source ↗

Summary

The clinical trial 'GCC 1619' evaluating lung SBRT motion management conducted by the University of Maryland has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Lung Cancer | Status: TERMINATED